Office Based Opioid Treatment

Similar Posts

  • NAMA-R NorthEast Recovery

    Admin 10/14/2022

    NAMA-R NorthEast Recovery Serving the New England Region Massachusetts, Maine, Rhode Island Connecticuit, New Hampshire and Vermont Welcome to Our Web Site! This website is for all Patients in Medication Assisted Treatment. NAMA-R NorthEast Recovery Includes Program Staff and Healthcare Professionals. We Believe That We Have A Lot To Offer Each Other. The National Alliance…

  • NAMA Policy Statement: Bottle Recall

    Admin 12/30/2021

    The intent of Bottle Recall initially was to be able to allow patients take home medication and to insure that methadone is not diverted to the streets. However, methadone programs have been giving patients take home medication for years without a serious methadone diversion problem. Furthermore numerous studies have demonstrated that methadone is not a…

  • The Pharmacology of Opioids

    Admin 04/18/2023

    Basic Pharmacology:  How Methadone Works Part 2 Basic Opioid Pharmacology All natural and synthetic opioids exhibit a three dimensional T-shaped configuration (Barchas, Berger, Ciaranello and Elliott, 1977). This T-shaped molecule has two broad hydrophobic surfaces which are at right angles and a methylated nitrogen which is usually charged at physiological pH. The charged nitrogen is…

  • NAMA

    Admin 04/23/2021

    Telling The Untold Methadone Success Stories This Treatment Works “There may be no more effective way to contain heroin abuse than methadone, a drug that blocks an addict’s craving. Yet new efforts to expand use of methadone have inspired new attacks on it, attacks that deny common sense.“ -The New York Times, April 8, 1990…

  • |

    Frequently Asked Questions About the Proposed New Methadone Regulations

    Admin 09/25/2021

    Substance Abuse Mental Health Services Administration FAQ July 22, 1999 1. Why is the Department of Health and Human Services (HHS) moving away from direct federal inspection by the FDA to surveys by accreditation organizations? HHS is proposing to move to an accreditation system to improve the quality of treatment for patients. While FDA regulation…

  • Publication Index

    Admin 03/18/2022

    FOR IMMEDIATE RELEASE: October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA),…